{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:19:49Z","timestamp":1783635589589,"version":"3.55.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"DOI":"10.1186\/s13044-025-00282-3","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T18:33:59Z","timestamp":1767638039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Another pleiotropic effect of SGLT2 inhibitors: Is it a new frontier in thyroid function regulation?"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4841-3774","authenticated-orcid":false,"given":"Micha\u0142","family":"Szklarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wo\u0142os-K\u0142osowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Szulc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"G\u00f3rny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Modzelewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Matuszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"282_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","volume":"7","author":"WM Tunbridge","year":"1977","unstructured":"Tunbridge WM, Evered DC. Hall R i wsp. The spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol (Oxf). 1977;7:481\u201393","journal-title":"Clin Endocrinol (Oxf)"},{"key":"282_CR2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1464-5491.1995.tb00553.x","volume":"12","author":"P Perros","year":"1995","unstructured":"Perros P, McCrimmon RJ. Shaw G i wsp. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995;12:622\u201327","journal-title":"Diabet Med"},{"key":"282_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/(SICI)1096-9136(199802)15:2<148::AID-DIA540>3.0.CO;2-H","volume":"15","author":"MJ Smithson","year":"1998","unstructured":"Smithson MJ. Screening for thyroid dysfunction in a community population of diabetic patients. Diabet Med. 1998;15:148\u201350","journal-title":"Diabet Med"},{"key":"282_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","volume":"43","author":"MP Vanderpump","year":"1995","unstructured":"Vanderpump MP, Tunbridge WM, Wsp FJM. The incidence of thyroid disorders in the community: a twenty-year follow-up of Whickham Survey. Clin Endocrinol. 1995;43:55\u201368","journal-title":"Clin Endocrinol"},{"key":"282_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-0031-1271691","volume":"119","author":"JJ Diez","year":"2011","unstructured":"Diez JJ, Sanchez P, Iglesias P. Prevalence of thyroid dysfunction in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2011;119:201\u201307","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"282_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1530\/eje.0.1470443","volume":"147","author":"PR Gallas","year":"2002","unstructured":"Gallas PR, Stolk RP, Bakker K, et al. Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. Eur J Endocrinol. 2002;147:443\u201351","journal-title":"Eur J Endocrinol"},{"key":"282_CR7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2337\/diacare.26.4.1181","volume":"26","author":"GE Umpierrez","year":"2003","unstructured":"Umpierrez GE, Latif KA, Murphy MB, et al. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care. 2003;26:1181\u201385","journal-title":"Diabetes Care"},{"key":"282_CR8","first-page":"376","volume":"67","author":"V der Driessche A","year":"2009","unstructured":"Van der Driessche A, Eenkhoorn V, Van Gaal L, et al. Type 1 diabetes and polyglandular syndrome: a clinical review. Neth J Med. 2009;67:376\u201387","journal-title":"Neth J Med"},{"key":"282_CR9","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1080\/00016340802499261","volume":"87","author":"M Vestgaard","year":"2008","unstructured":"Vestgaard M, Nielsen LR, Rasmussen AK, et al. Thyroid peroxidase antibodies in pregnant women with type 1 diabetes: impact on thyroid function, metabolic control and pregnancy outcome. Acta Obstet Gynecol Scand. 2008;87:1336\u201342","journal-title":"Acta Obstet Gynecol Scand"},{"key":"282_CR10","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I. Danzi S thyroid disease and the heart. Circulation. 2007;116:1725\u201335","journal-title":"Circulation"},{"issue":"22","key":"282_CR11","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE. EMPA-REG outcome investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015, Nov, 26;373(22):2117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1504720.","journal-title":"N Engl J Med"},{"issue":"6","key":"282_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.123.067584","volume":"149","author":"BL Neuen","year":"2024","unstructured":"Neuen BL, Heerspink HJL, Vart P, Claggett BL, Fletcher RA, Arnott C, et al. Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria. Circulation. 2024, Feb, 6;149(6):450\u201362. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067584. Epub 2023 Nov 12. PMID: 37952217","journal-title":"Circulation"},{"issue":"7","key":"282_CR13","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.3390\/ijms23073668","volume":"23","author":"L Mirarchi","year":"2022","unstructured":"Mirarchi L, Amodeo S, Citarrella R, Licata A, Soresi M, Giannitrapani L. SGLT2 inhibitors as the most promising influencers on the outcome of non-alcoholic fatty liver disease. Int J Mol Sci. 2022, Mar, 27;23(7):3668. https:\/\/doi.org\/10.3390\/ijms23073668. PMID: 35409028; PMCID: PMC8998221","journal-title":"Int J Mol Sci"},{"issue":"83","key":"282_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","volume":"10","author":"V Vallon","year":"2021","unstructured":"Vallon V, Verma S. Effects of SGLT2 inhibitors on kidney and cardiovascular function. Annu Rev Physiol. 2021, Feb;10(83):503\u201328. https:\/\/doi.org\/10.1146\/annurev-physiol-031620-095920. Epub 2020 Nov 16. PMID: 33197224; PMCID: PMC8017904","journal-title":"Annu Rev Physiol"},{"issue":"23","key":"282_CR15","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.3390\/molecules26237213","volume":"26","author":"A Pawlos","year":"2021","unstructured":"Pawlos A, Broncel M, Wo\u017aniak E, Gorzelak-Pabi\u015b P. Neuroprotective effect of SGLT2 inhibitors. Molecules. 2021, Nov, 28;26(23):7213. https:\/\/doi.org\/10.3390\/molecules26237213. PMID: 34885795; PMCID: PMC8659196","journal-title":"Molecules"},{"key":"282_CR16","doi-asserted-by":"crossref","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74:1376\u2013414","DOI":"10.1016\/j.jacc.2019.03.009"},{"issue":"11","key":"282_CR17","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","volume":"126","author":"RH Ritchie","year":"2020","unstructured":"Ritchie RH, Abel ED. Basic mechanisms of diabetic heart disease. Circ Res. 2020;126(11):1501\u20131525.https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.315913.","journal-title":"Circ Res"},{"key":"282_CR18","unstructured":"Regional Commemoration of World Diabetes Day 2024: meeting report, 21\u201322 November 2024; Colombo, Sri Lanka. 2024."},{"issue":"11","key":"282_CR19","doi-asserted-by":"publisher","first-page":"e13260","DOI":"10.1111\/acel.13260","volume":"19","author":"BR Gauthier","year":"2020","unstructured":"Gauthier BR, Sola-Garc\u00eda A, C\u00e1liz-Molina M\u00c1, Lorenzo PI, Cobo-Vuilleumier N, Capilla-Gonz\u00e1lez V, Martin-Montalvo A. Thyroid hormones in diabetes, cancer, and aging. Aging Cell. 2020, Nov;19(11):e13260. https:\/\/doi.org\/10.1111\/acel.13260. Epub 2020 Oct 13. PMID: 33048427; PMCID: PMC7681062","journal-title":"Aging Cell"},{"issue":"2","key":"282_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","volume":"94","author":"R Mullur","year":"2014","unstructured":"Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014, Apr;94(2):355\u201382. https:\/\/doi.org\/10.1152\/physrev.00030.2013. PMID: 24692351; PMCID: PMC4044302","journal-title":"Physiol Rev"},{"issue":"1","key":"282_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12902-023-01393-4","volume":"23","author":"H Iwakura","year":"2023","unstructured":"Iwakura H, Takagi T, Inaba H, Doi A, Ueda Y, Uraki S, Takeshima K, Furukawa Y, Ishibashi T, Morita S, Matsuno S, Nishi M, Furuta H, Matsuoka TA, Akamizu T. Thyroid function, glycemic control, and diabetic nephropathy in patients with type 2 diabetes over 24 months: prospective observational study. BMC Endocr Disord. 2023, Jul, 10;23(1):146. https:\/\/doi.org\/10.1186\/s12902-023-01393-4. PMID: 37430240; PMCID: PMC10332001","journal-title":"BMC Endocr Disord"},{"issue":"8","key":"282_CR22","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.3390\/ijms21083020","volume":"21","author":"WW Yau","year":"2020","unstructured":"Yau WW, Yen PM. Thermogenesis in adipose tissue activated by thyroid hormone. Int J Mol Sci. 2020, Apr, 24;21(8):3020. https:\/\/doi.org\/10.3390\/ijms21083020. PMID: 32344721; PMCID: PMC7215895","journal-title":"Int J Mol Sci"},{"issue":"2","key":"282_CR23","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1210\/jc.2004-1768","volume":"90","author":"LC Moeller","year":"2005","unstructured":"Moeller LC, Dumitrescu AM, Walker RL, Meltzer PS, Refetoff S. Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab. 2005, Feb;90(2):936\u201343. https:\/\/doi.org\/10.1210\/jc.2004-1768. Epub 2004 Oct 26. PMID: 15507505","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"282_CR24","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1210\/mend.14.7.0470","volume":"14","author":"X Feng","year":"2000","unstructured":"Feng X, Jiang Y, Meltzer P, Yen PM. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol. 2000, July, 1;14(7):947\u201355. https:\/\/doi.org\/10.1210\/mend.14.7.0470","journal-title":"Mol Endocrinol"},{"issue":"5","key":"282_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrendo.2018.10","volume":"14","author":"RA Sinha","year":"2018","unstructured":"Sinha RA, Singh BK, Yen PM. Direct effects of thyroid hormones on hepatic lipid metabolism. Nat Rev Endocrinol. 2018, May;14(5):259\u201369. https:\/\/doi.org\/10.1038\/nrendo.2018.10. Epub 2018 Feb 23. PMID: 29472712; PMCID: PMC6013028","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"282_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4093\/dmj.2022.0013","volume":"46","author":"YS Eom","year":"2022","unstructured":"Eom YS, Wilson JR, Bernet VJ. Links between thyroid disorders and glucose homeostasis. Diabetes Metab J. 2022, Mar;46(2):239\u201356. https:\/\/doi.org\/10.4093\/dmj.2022.0013. Epub 2022 Mar 24. PMID: 35385635; PMCID: PMC8987680","journal-title":"Diabetes Metab J"},{"key":"282_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1210\/er.2009-0046","volume":"31","author":"P Mitrou","year":"2010","unstructured":"Mitrou P, Raptis SA, Dimitriadis G. Insulin action in hyperthyroidism: a focus on muscle and adipose tissue. Endocr Rev. 2010;31:663\u201379","journal-title":"Endocr Rev"},{"key":"282_CR28","first-page":"983","volume":"76","author":"L Bartalena","year":"1993","unstructured":"Bartalena L, Cossu E, Wsp GL. Relationship between nocturnal serum thyrotropin peak and metabolic control in diabetic patients. J Clin Endocrinol Metab. 1993;76:983\u201387","journal-title":"J Clin Endocrinol Metab"},{"key":"282_CR29","first-page":"185","volume-title":"Wielka Interna, Endokrynologia cz","author":"M Gietka-Czernel","year":"2011","unstructured":"Gietka-Czernel M. Diagnostyka laboratoryjna chor\u00f3b tarczycy. In: Zgliczy\u0144ski W, editor. Wielka Interna, Endokrynologia cz. Warszawa: I. Medical Tribune Polska; 2011. p. 185\u201397"},{"issue":"4","key":"282_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1365-2362.2007.01786.x","volume":"37","author":"E Maratou","year":"2007","unstructured":"Maratou E, Dimitriadis G, Kollias A, Boutati E, Lambadiari V, Mitrou P, Raptis SA. Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur J Clin Invest. 2007, Apr;37(4):282\u201390. https:\/\/doi.org\/10.1111\/j.1365-2362.2007.01786.x. PMID: 17373964","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"282_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fphys.2015.00237","volume":"21","author":"A Lombardi","year":"2015","unstructured":"Lombardi A, Moreno M, de Lange P, Iossa S, Busiello RA, Goglia F. Regulation of skeletal muscle mitochondrial activity by thyroid hormones: focus on the \u201cold\u201d triiodothyronine and the \u201cemerging\u201d 3,5-diiodothyronine. Front Physiol. 2015, Aug;21(6):237. https:\/\/doi.org\/10.3389\/fphys.2015.00237. PMID: 26347660; PMCID: PMC4543916","journal-title":"Front Physiol"},{"key":"282_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-1-4939-7902-8_14","volume":"1801","author":"C Wrutniak-Cabello","year":"2018","unstructured":"Wrutniak-Cabello C, Casas F, Cabello G. Thyroid hormone action: the p43 mitochondrial pathway. Methods Mol Biol. 2018;1801:163\u201381. https:\/\/doi.org\/10.1007\/978-1-4939-7902-8_14. PMID: 29892824","journal-title":"Methods Mol Biol"},{"issue":"5","key":"282_CR33","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.3390\/ijms22052489","volume":"22","author":"E Blanchet","year":"2021","unstructured":"Blanchet E, Pessemesse L, Feillet-Coudray C, Coudray C, Cabello C, Bertrand-Gaday C, Casas F. p43, a truncated form of thyroid hormone receptor \u03b1, regulates maturation of pancreatic \u03b2 cells. Int J Mol Sci. 2021, Mar, 2;22(5):2489. https:\/\/doi.org\/10.3390\/ijms22052489. PMID: 33801253; PMCID: PMC7958131","journal-title":"Int J Mol Sci"},{"issue":"Suppl, 2:","key":"282_CR34","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1055\/s-2001-18584","volume":"109","author":"GD Dimitriadis","year":"2001","unstructured":"Dimitriadis GD, Raptis SA. Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes. 2001;109(Suppl, 2:):S225\u201339. https:\/\/doi.org\/10.1055\/s-2001-18584. PMID: 11460573","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"282_CR35","doi-asserted-by":"publisher","first-page":"e0128546","DOI":"10.1371\/journal.pone.0128546","volume":"10","author":"J Ikeda","year":"2015","unstructured":"Ikeda J, Ichiki T, Takahara Y, Kojima H, Sankoda C, Kitamoto S, Tokunou T, Sunagawa K. PPAR\u03b3 Agonists attenuate palmitate-induced er stress through up-regulation of SCD-1 in macrophages. PLoS ONE. 2015, Jun, 10;10(6):e0128546. https:\/\/doi.org\/10.1371\/journal.pone.0128546. PMID: 26061913; PMCID: PMC4464548","journal-title":"PLoS One"},{"issue":"12","key":"282_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.tem.2017.10.003","volume":"28","author":"AM ALJohani","year":"2017","unstructured":"ALJohani AM, Syed DN, Ntambi JM. Insights into stearoyl-CoA desaturase-1 regulation of systemic metabolism. Trends Endocrinol Metab. 2017, Dec;28(12):831\u201342. https:\/\/doi.org\/10.1016\/j.tem.2017.10.003. Epub 2017 Oct 28. PMID: 29089222; PMCID: PMC5701860","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"282_CR37","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/jcp.29026","volume":"235","author":"A Dziewulska","year":"2020","unstructured":"Dziewulska A, Dobosz AM, Dobrzyn A, Smolinska A, Kolczynska K, Ntambi JM, Dobrzyn P. SCD1 regulates the AMPK\/SIRT1 pathway and histone acetylation through changes in adenine nucleotide metabolism in skeletal muscle. J Cell Physiol. 2020, Feb;235(2):1129\u201340. https:\/\/doi.org\/10.1002\/jcp.29026. Epub 2019 Jun 26. PMID: 31241768","journal-title":"J Cell Physiol"},{"key":"282_CR38","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41423-023-01011-2","volume":"20","author":"E Grajchen","year":"2023","unstructured":"Grajchen E, Loix M, Baeten P, et al. Fatty acid desaturation by stearoyl-CoA desaturase-1 controls regulatory T cell differentiation and autoimmunity. Cell Mol Immunol. 2023;20:666\u201379. https:\/\/doi.org\/10.1038\/s41423-023-01011-2","journal-title":"Cell Mol Immunol"},{"issue":"13","key":"282_CR39","doi-asserted-by":"publisher","first-page":"1037969","DOI":"10.3389\/fendo.2022.1037969","volume":"18","author":"J Lin","year":"2022","unstructured":"Lin J, Xiang X, Qin Y, Gui J, Wan Q. Correlation of thyroid-related hormones with vascular complications in type 2 diabetes patients with euthyroid. Front Endocrinol (Lausanne). 2022, Nov;18(13):1037969. https:\/\/doi.org\/10.3389\/fendo.2022.1037969. PMID: 36465631; PMCID: PMC9715611","journal-title":"Front Endocrinol (lausanne)"},{"issue":"12","key":"282_CR40","doi-asserted-by":"publisher","first-page":"e50848","DOI":"10.7759\/cureus.50848","volume":"15","author":"S Vudu","year":"2023","unstructured":"Vudu S, Behnke A. C-reactive Protein levels in patients with autoimmune hypothyroidism before and after levothyroxine treatment. Cureus. 2023, Dec, 20;15(12):e50848. https:\/\/doi.org\/10.7759\/cureus.50848. PMID: 38249164; PMCID: PMC10798680","journal-title":"Cureus"},{"issue":"2","key":"282_CR41","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00268-009-0344-4","volume":"34","author":"A Itoh","year":"2010","unstructured":"Itoh A, Iwase K, Jimbo S, Yamamoto H, Yamamoto N, Kokubo M, Senda T, Nakai A, Nagagasaka A, Nagasaka T, Hibi Y, Seko T. Expression of vascular endothelial growth factor and presence of angiovascular cells in tissues from different thyroid disorders. World J Surg. 2010, Feb;34(2):242\u201348. https:\/\/doi.org\/10.1007\/s00268-009-0344-4. PMID: 20041248","journal-title":"World J Surg"},{"issue":"8","key":"282_CR42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/BF03347350","volume":"26","author":"F Azizi","year":"2003","unstructured":"Azizi F, Raiszadeh F, Solati M, Etemadi A, Rahmani M, Arabi M. Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest. 2003, Aug;26(8):703\u201309. https:\/\/doi.org\/10.1007\/BF03347350. PMID: 14669822","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"282_CR43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1515\/hmbci-2021-0029","volume":"43","author":"N Kumar Singh","year":"2022","unstructured":"Kumar Singh N, Suri A, Kumari M, Kaushik P. A study on serum homocysteine and oxidized LDL as markers of cardiovascular risk in patients with overt hypothyroidism. Horm Mol Biol Clin Investig. 2022, Feb, 17;43(3):329\u201335. https:\/\/doi.org\/10.1515\/hmbci-2021-0029. PMID: 35179003","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"22","key":"282_CR44","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.2169\/internalmedicine.55.7147","volume":"55","author":"H Wakasaki","year":"2016","unstructured":"Wakasaki H, Matsumoto M, Tamaki S, Miyata K, Yamamoto S, Minaga T, Hayashi Y, Komukai K, Imanishi T, Yamaoka H, Matsuno S, Nishi M, Akamizu T. Resistance to thyroid hormone Complicated with type 2 diabetes and cardiomyopathy in a patient with a TR\u03b2 mutation. Intern Med. 2016;55(22):3295\u201399. https:\/\/doi.org\/10.2169\/internalmedicine.55.7147. Epub 2016 Nov 15. PMID: 27853072; PMCID: PMC5173497","journal-title":"Intern Med"},{"key":"282_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainres.2011.04.005","volume":"1392","author":"MD Pinazo-Dur\u00e1n","year":"2011","unstructured":"Pinazo-Dur\u00e1n MD, Pons-V\u00e1zquez S, Gallego-Pinazo R, Galbis Estrada C, Zan\u00f3n-Moreno V, Vila Bou V, Sanz Solana P. Thyroid hormone deficiency disrupts rat eye neurodevelopment. Brain Res. 2011, May, 25;1392:16\u201326. https:\/\/doi.org\/10.1016\/j.brainres.2011.04.005. Epub 2011 Apr 9.Erratum in:Brain Res.2012 Mar 29;1446:156. PMID: 21529787","journal-title":"Brain Res"},{"issue":"1","key":"282_CR46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/15569527.2015.1007509","volume":"35","author":"T Kocaturk","year":"2016","unstructured":"Kocaturk T, Ergin K, Cesur G, Evlicoglu GE, Cakmak H. The effect of methimazole-induced postnatal hypothyroidism on the retinal maturation and on the Sirtuin 2 level. Cutan Ocul Toxicol. 2016, Mar;35(1):36\u201340. https:\/\/doi.org\/10.3109\/15569527.2015.1007509. Epub 2015 Mar 11. PMID: 25758293","journal-title":"Cutan Ocul Toxicol"},{"issue":"10","key":"282_CR47","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1089\/thy.2014.0190","volume":"24","author":"T Ittermann","year":"2014","unstructured":"Ittermann T, D\u00f6rr M, V\u00f6lzke H, Tost F, Lehmphul I, K\u00f6hrle J, J\u00fcrgens C. High serum thyrotropin levels are associated with retinal arteriolar narrowing in the general population. Thyroid. 2014, Oct;24(10):1473\u201378. https:\/\/doi.org\/10.1089\/thy.2014.0190. PMID: 25156414","journal-title":"Thyroid"},{"key":"282_CR48","doi-asserted-by":"publisher","unstructured":"Wu J, Yue S, Geng J, Liu L, Teng W, Liu L, Chen L. Relationship between diabetic retinopathy and subclinical hypothyroidism: a meta-analysis. Sci Rep. 2015 Jul 20;5: 12212. https:\/\/doi.org\/10.1038\/srep12212. PMID: 26193340; PMCID: PMC4507396","DOI":"10.1038\/srep12212"},{"issue":"2","key":"282_CR49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.5603\/EP.a2020.0013","volume":"71","author":"MM Stefanowicz-Rutkowska","year":"2020","unstructured":"Stefanowicz-Rutkowska MM, Baranowska-Jurkun A, Matuszewski W, Bandurska-Stankiewicz EM. Thyroid dysfunction in patients with diabetic retinopathy. Endokrynol Pol. 2020;71(2):176\u201383. https:\/\/doi.org\/10.5603\/EP.a2020.0013. PMID: 32396211","journal-title":"Endokrynol Pol"},{"key":"282_CR50","unstructured":"Sowi\u0144ski J, Czupryniak L, Milewicz A, Hubalewska-Dydejczyk A, Szelachowska M, Rucha\u0142a M, Lewi\u0144ski A, G\u00f3rska M, Siewko K, Wender-O\u017cegowska E, Zozuli\u0144ska-Zi\u00f3\u0142kiewicz D, Junik R, Sawicka N, Gutaj P. Recommendations of the Polish Society of Endocrinology and Polish Diabetes Association for the management of thyroid dysfunction in type 1 and type 2 diabetes = Zalecenia Polskiego Towarzystwa Endokrynologicznego oraz Polskiego Towarzystwa Diabetologicznego dotycz\u0105ce diagnostyki i leczenia zaburze\u0144 funkcji tarczycy w cukrzycy typu 1 i 2. Endokrynologia Polska (Pol J Endocrinol). 2013;64, Article 1. https:\/\/journals.viamedica.pl\/endokrynologia_polska\/article\/view\/34308\/25119"},{"key":"282_CR51","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","volume":"62","author":"K \u0141abuzek","year":"2010","unstructured":"\u0141abuzek K, Suchy D, Wsp GB. Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep. 2010;62:956\u201365","journal-title":"Pharmacol Rep"},{"key":"282_CR52","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2337\/dc09-0273","volume":"32","author":"C Cappelli","year":"2009","unstructured":"Cappelli C, Rotondi M, Wsp PI. TSH-lowering effect of metformin in 16. type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care. 2009;32:1589\u201390","journal-title":"Diabetes Care"},{"key":"282_CR53","first-page":"471","volume":"3","author":"MR England","year":"1986","unstructured":"England MR, Hartnell JM, Wsp HJM. Glyburide does not alter thyroid function. Diabetes Res. 1986;3:471\u201374","journal-title":"Diabetes Res"},{"key":"282_CR54","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","volume":"132","author":"AE Hak","year":"2000","unstructured":"Hak AE, Pols HA, Wsp VTJ. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the rotterdam study. Ann Intern Med. 2000;132:270\u201378","journal-title":"Ann Intern Med"},{"key":"282_CR55","first-page":"362","volume":"62","author":"A Hubalewska-Dydejczyk","year":"2011","unstructured":"Hubalewska-Dydejczyk A, Bandurska-Stankiewicz E, Bar-Andziak E, et al. Management of thyroid diseases during pregnancy. Pol J Endocrinol. 2011;62:362\u201381","journal-title":"Pol J Endocrinol"},{"key":"282_CR56","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/152850","author":"G Brenta","year":"2011","unstructured":"Brenta G. Why can insulin resistance be a natural consequence of thyroid dysfunction? J Thyroid Res. 2011, Epub. doi: https:\/\/doi.org\/10.4061\/2011\/152850","journal-title":"J Thyroid Res"},{"issue":"1","key":"282_CR57","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.etap.2015.06.009","volume":"40","author":"ER Kabir","year":"2015","unstructured":"Kabir ER, Rahman MS, Rahman I. A review on endocrine disruptors and their possible impacts on human health. Environ Toxicol Pharmacol. 2015, Jul;40(1):241\u201358. https:\/\/doi.org\/10.1016\/j.etap.2015.06.009. Epub 2015 Jun 9. PMID: 26164742","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"282_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11154-019-09521-z","volume":"21","author":"B Yilmaz","year":"2020","unstructured":"Yilmaz B, Terekeci H, Sandal S, Kelestimur F. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention. Rev Endocr Metab Disord. 2020, Mar;21(1):127\u201347. https:\/\/doi.org\/10.1007\/s11154-019-09521-z. PMID: 31792807","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"282_CR59","doi-asserted-by":"publisher","first-page":"101377","DOI":"10.1016\/j.beem.2020.101377","volume":"34","author":"S Benvenga","year":"2020","unstructured":"Benvenga S, Elia G, Ragusa F, Paparo SR, Sturniolo MM, Ferrari SM, Antonelli A, Fallahi P. Endocrine disruptors and thyroid autoimmunity. Best Pract researchclin Endocrinol Metab. 2020, Jan;34(1):101377. https:\/\/doi.org\/10.1016\/j.beem.2020.101377. Epub 2020 Feb 11. PMID: 32081544","journal-title":"Best Pract researchclin Endocrinol Metab"},{"issue":"2","key":"282_CR60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.eprac.2023.11.002","volume":"30","author":"EN Pearce","year":"2024","unstructured":"Pearce EN. Endocrine disruptors and thyroid health. Endocr Pract. 2024, Feb;30(2):172\u201376. https:\/\/doi.org\/10.1016\/j.eprac.2023.11.002. Epub 2023 Nov 11. PMID: 37956907","journal-title":"Endocr Pract"},{"issue":"59","key":"282_CR61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-pharmtox-010818-021304","volume":"6","author":"JJ Heindel","year":"2019","unstructured":"Heindel JJ, Blumberg B. Environmental obesogens: mechanisms and controversies. Annu Rev Pharmacol Toxicol. 2019, Jan;6(59):89\u2013106. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021304. Epub 2018 Jul 25. PMID: 30044726; PMCID: PMC6559802","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9","key":"282_CR62","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/medicina55090515","volume":"55","author":"U Shahnazaryan","year":"2019","unstructured":"Shahnazaryan U, W\u00f3jcik M, Bednarczuk T, Kury\u0142owicz A. Role of obesogens in the pathogenesis of obesity. Medicina (Kaunas). 2019, Aug, 21;55(9):515. https:\/\/doi.org\/10.3390\/medicina55090515. PMID: 31438630; PMCID: PMC6780315","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"282_CR63","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1530\/JOE-16-0450","volume":"233","author":"X Meng","year":"2017","unstructured":"Meng X, Xu S, Chen G, Derwahl M, Liu C. Metformin and thyroid disease. J Endocrinol. 2017, Apr;233(1):R43\u201351. https:\/\/doi.org\/10.1530\/JOE-16-0450. Epub 2017 Feb 14. PMID: 28196954","journal-title":"J Endocrinol"},{"issue":"1","key":"282_CR64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000346248","volume":"2","author":"T Pappa","year":"2013","unstructured":"Pappa T, Alevizaki M. Metformin and thyroid: an update. Eur Thyroid J. 2013, Mar;2(1):22\u201328. https:\/\/doi.org\/10.1159\/000346248. Epub 2013 Jan 19. PMID: 24783035; PMCID: PMC3821496","journal-title":"Eur Thyroid J"},{"issue":"4","key":"282_CR65","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/biom12040574","volume":"12","author":"M Garc\u00eda-S\u00e1enz","year":"2022","unstructured":"Garc\u00eda-S\u00e1enz M, Lobaton-Ginsberg M, Ferreira-Hermosillo A. Metformin in differentiated thyroid cancer: molecular pathways and its clinical implications. Biomolecules. 2022, Apr, 14;12(4):574. https:\/\/doi.org\/10.3390\/biom12040574. PMID: 35454163; PMCID: PMC9029304","journal-title":"Biomolecules"},{"issue":"12","key":"282_CR66","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1055\/a-2374-8756","volume":"56","author":"A Chauhan","year":"2024","unstructured":"Chauhan A, Patel SS. Thyroid hormone and diabetes mellitus interplay: making Management of comorbid disorders Complicated. Horm Metab Res. 2024, Dec;56(12):845\u201358. https:\/\/doi.org\/10.1055\/a-2374-8756. Epub 2024 Aug 19. PMID: 39159661","journal-title":"Horm Metab Res"},{"issue":"5","key":"282_CR67","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/030006057600400512","volume":"4","author":"BK Adadevoh","year":"1976","unstructured":"Adadevoh BK. Sulphonylurea and hypothyroidism in Nigerian diabetic subjects. J Int Med Res. 1976;4(5):364\u201366. https:\/\/doi.org\/10.1177\/030006057600400512. PMID: 1028637","journal-title":"J Int Med Res"},{"issue":"4","key":"282_CR68","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/thy.2023.0530","volume":"34","author":"AE Espinosa De Ycaza","year":"2024","unstructured":"Espinosa De Ycaza AE, Brito JP, Rg M, Shao H, Singh Ospina N. Glucagon-like peptide-1 receptor Agonists and thyroid cancer: a Narrative review. Thyroid. 2024, Apr;34(4):403\u201318. https:\/\/doi.org\/10.1089\/thy.2023.0530. Epub 2024 Mar 26. PMID: 38343381; PMCID: PMC10998705","journal-title":"Thyroid"},{"issue":"2","key":"282_CR69","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40618-024-02463-7","volume":"48","author":"C Zhang","year":"2025","unstructured":"Zhang C, Liu A, Teng W, Yang W, Li J, Shan Z. Effects of acarbose and metformin on thyroid function and thyroid hormone sensitivity in type 2 diabetes patients: a post-hoc analysis of the march study. J Endocrinol Invest. 2025, Feb;48(2):419\u201333. https:\/\/doi.org\/10.1007\/s40618-024-02463-7. Epub 2024 Oct 14. PMID: 39400888","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"282_CR70","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2415-7-8","volume":"26","author":"S Lee","year":"2007","unstructured":"Lee S, Tsirbas A, Goldberg RA, McCann JD. Thiazolidinedione induced thyroid associated orbitopathy. BMC Ophthalmol. 2007, Apr;26(7):8. https:\/\/doi.org\/10.1186\/1471-2415-7-8. PMID: 17462097; PMCID: PMC1876204","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"282_CR71","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/2042018816658396","volume":"7","author":"N Jain","year":"2016","unstructured":"Jain N, Savani M, Agarwal M, Kadaria D. Methimazole-induced insulin autoimmune syndrome. Ther Adv Endocrinol Metab. 2016, Aug;7(4):178\u201381. https:\/\/doi.org\/10.1177\/2042018816658396. Epub 2016 Jul 19. PMID: 27540463; PMCID: PMC4973408","journal-title":"Ther Adv Endocrinol Metab"},{"key":"282_CR72","doi-asserted-by":"publisher","unstructured":"Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res. 2011, 2011;439463. https:\/\/doi.org\/10.4061\/2011\/439463. Epub 2011 Jul 12. PMID: 21785689; PMCID: PMC3139205","DOI":"10.4061\/2011\/439463"},{"key":"282_CR73","doi-asserted-by":"publisher","unstructured":"Tang Y, Yan T, Wang G, Chen Y, Zhu Y, Jiang Z, Yang M, Li C, Li Z, Yu P, Wang S, Zhu N, Ren Q, Ni C. Correlation between insulin resistance and thyroid nodule in type 2 diabetes mellitus. Int J Endocrinol. 2017, 2017;1617458. https:\/\/doi.org\/10.1155\/2017\/1617458. Epub 2017 Oct 12. PMID: 29158735; PMCID: PMC5660821","DOI":"10.1155\/2017\/1617458"},{"issue":"7 Suppl","key":"282_CR74","first-page":"s176","volume":"22","author":"CM Apovian","year":"2016","unstructured":"Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016, Jun;22(7 Suppl):s176\u201385. PMID: 27356115","journal-title":"Am J Manag Care"},{"issue":"4","key":"282_CR75","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13679-017-0283-6","volume":"6","author":"KL Marlatt","year":"2017","unstructured":"Marlatt KL, Ravussin E. Brown adipose tissue: an update on recent findings. Curr Obes Rep. 2017, Dec;6(4):389\u201396. https:\/\/doi.org\/10.1007\/s13679-017-0283-6. PMID: 29101739; PMCID: PMC5777285","journal-title":"Curr Obes Rep"},{"issue":"7","key":"282_CR76","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/oby.2012.78","volume":"20","author":"van der Veen Dr","year":"2012","unstructured":"van der Veen Dr, Shao J, Chapman S, Leevy WM, Duffield GE. A diurnal rhythm in glucose uptake in brown adipose tissue revealed by in vivo PET-FDG imaging. Obes (Silver Spring). 2012, Jul;20(7):1527\u201329. https:\/\/doi.org\/10.1038\/oby.2012.78. Epub 2012 Mar 26. PMID: 22447290; PMCID: PMC3383904","journal-title":"Obes (silver Spring)"},{"key":"282_CR77","doi-asserted-by":"publisher","unstructured":"Al-Musa HM. Impact of obesity on serum levels of thyroid hormones among euthyroid Saudi adults. J Thyroid Res. 2017, 2017;5739806. https:\/\/doi.org\/10.1155\/2017\/5739806. Epub 2017 May 22. PMID: 28630779; PMCID: PMC5463130","DOI":"10.1155\/2017\/5739806"},{"issue":"12","key":"282_CR78","doi-asserted-by":"publisher","first-page":"706101","DOI":"10.3389\/fendo.2021.706101","volume":"2","author":"R Latif","year":"2021","unstructured":"Latif R, Ma R, Morshed SA, Tokat B, Davies TF. Long term rescue of the TSH receptor knock-out mouse - thyroid Stem cell transplantation restores thyroid function. Front Endocrinol (Lausanne). 2021, Jul;2(12):706101. https:\/\/doi.org\/10.3389\/fendo.2021.706101. PMID: 34276566; PMCID: PMC8283971","journal-title":"Front Endocrinol (lausanne)"},{"issue":"5","key":"282_CR79","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fphys.2014.00479","volume":"11","author":"MJ Obregon","year":"2014","unstructured":"Obregon MJ. Adipose tissues and thyroid hormones. Front Physiol. 2014, Dec;11(5):479. https:\/\/doi.org\/10.3389\/fphys.2014.00479. PMID: 25566082; PMCID: PMC4263094","journal-title":"Front Physiol"},{"issue":"1","key":"282_CR80","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/15548627.2018.1511263","volume":"15","author":"WW Yau","year":"2019","unstructured":"Yau WW, Singh BK, Lesmana R, Zhou J, Sinha RA, Wong KA, Wu Y, Bay BH, Sugii S, Sun L, Yen PM. Thyroid hormone (T3) stimulates brown adipose tissue activation via mitochondrial biogenesis and MTOR-mediated mitophagy. Autophagy. 2019, Jan;15(1):131\u201350. https:\/\/doi.org\/10.1080\/15548627.2018.1511263. Epub 2018 Sep 13. PMID: 30209975; PMCID: PMC6287687","journal-title":"Autophagy"},{"issue":"4","key":"282_CR81","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41419-021-03634-7","volume":"12","author":"XH Zhang","year":"2021","unstructured":"Zhang XH, Tang LY, Wang XY, Shen CL, Xiong WF, Shen Y, Wan YH, Wu YB, Wang YC, Zhang HX, Lu SY, Fei J, Wang ZG. ADGRA1 negatively regulates energy expenditure and thermogenesis through both sympathetic nervous system and hypothalamus-pituitary-thyroid axis in male mice. Cell Death Dis. 2021, Apr, 6;12(4):362. https:\/\/doi.org\/10.1038\/s41419-021-03634-7. PMID: 33824276; PMCID: PMC8024368","journal-title":"Cell Death Dis"},{"issue":"1","key":"282_CR82","doi-asserted-by":"publisher","first-page":"7838","DOI":"10.1038\/s41467-022-35470-4","volume":"13","author":"K Chen","year":"2022","unstructured":"Chen K, Cheong LY, Gao Y, Zhang Y, Feng T, Wang Q, Jin L, Honor\u00e9 E, Lam KSL, Wang W, Hui X, Xu A. Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nat Commun. 2022, Dec, 20;13(1):7838. https:\/\/doi.org\/10.1038\/s41467-022-35470-4. PMID: 36539421; PMCID: PMC9767940","journal-title":"Nat Commun"},{"issue":"8","key":"282_CR83","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1210\/jc.2010-1245","volume":"95","author":"B Biondi","year":"2010","unstructured":"Biondi B. Thyroid and obesity: an intriguing Relationship. The J Clin Endocrinol Metab. 2010, August, 1;95(8):3614\u201317. https:\/\/doi.org\/10.1210\/jc.2010-1245","journal-title":"The J Clin Endocrinol Metab"},{"issue":"7","key":"282_CR84","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI9725","volume":"105","author":"JS Flier","year":"2000","unstructured":"Flier JS, Harris M, Hollenberg AN. Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. J Clin Invest. 2000, Apr;105(7):859\u201361. https:\/\/doi.org\/10.1172\/JCI9725. PMID: 10749565; PMCID: PMC377492","journal-title":"J Clin Invest"},{"key":"282_CR85","doi-asserted-by":"publisher","first-page":"51733","DOI":"10.12775\/JEHS.2024.74.51733","volume":"74","author":"N Gajdzi\u0144ska","year":"2024","unstructured":"Gajdzi\u0144ska N, Salwa A, Rostkowska W, Rutkowski W, Sztuba K, Rzepka M, Basiura K, Rymaszewska K, Pucha\u0142a J, Starzomska D. Thyroid disfunction and obesity - What comes first? A complex relationship between hypothyroidism and weight gain. J Educ, Health And Sport. Online. 2024, June, 16;74:51733. https:\/\/doi.org\/10.12775\/JEHS.2024.74.51733. Accessed 5 August 2025","journal-title":"J Educ, Health And Sport. Online"},{"key":"282_CR86","doi-asserted-by":"publisher","unstructured":"Sosa-Lopez JG, et al. Impact of obesity on the thyroid profile, long-term experience at the general hospital of Mexico, \u201cDr. Eduardo Liceaga\u201d. Rev. Med. Hosp. Gen. M\u00e9x. [online]. 2021;84(n.1):4\u201310. Epub 22-Ene-2021. ISSN 2524-177X. https:\/\/doi.org\/10.24875\/hgmx.20000012","DOI":"10.24875\/hgmx.20000012"},{"issue":"6","key":"282_CR87","doi-asserted-by":"publisher","first-page":"e2365","DOI":"10.1210\/clinem\/dgac110","volume":"107","author":"Z Wu","year":"2022","unstructured":"Wu Z, Jiang Y, Zhou D, Chen S, Zhao Y, Zhang H, Liu Y, Li X, Wang W, Zhang J, Kang X, Tao L, Gao B, Guo X. Sex-specific Association of subclinical hypothyroidism with incident metabolic syndrome: a population-based cohort study. J Clin Endocrinol Metab. 2022, May, 17;107(6):e2365\u201372. https:\/\/doi.org\/10.1210\/clinem\/dgac110. PMID: 35213715","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"282_CR88","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1159\/000512665","volume":"10","author":"L Mehran","year":"2021","unstructured":"Mehran L, Amouzegar A, Abdi H, Delbari N, Madreseh E, Tohidi M, Mansournia MA, Azizi F. Incidence of thyroid dysfunction facing metabolic syndrome: a prospective comparative study with 9 years of follow-up. Eur Thyroid J. 2021, Jul;10(5):390\u201398. https:\/\/doi.org\/10.1159\/000512665. Epub 2021 Jan 27. PMID: 34540709; PMCID: PMC8406240","journal-title":"Eur Thyroid J"},{"key":"282_CR89","doi-asserted-by":"publisher","unstructured":"Rusza\u0142a A, W\u00f3jcik M, Starzyk JB. The impact of thyroid function on the occurrence of metabolic syndrome in obese children and adolescents. Pediatr Endocrinol Diabetes Metab. 2019;25(1):1\u20135. English. doi: https:\/\/doi.org\/10.5114\/pedm.2019.84705. PMID: 31343126","DOI":"10.5114\/pedm.2019.84705"},{"issue":"5","key":"282_CR90","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1530\/EJE-21-0634","volume":"185","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Park SJ, Park HK, Byun DW, Suh K, Yoo MH. Thyroid autoimmunity and metabolic syndrome: a nationwide population-based study. Eur J Endocrinol. 2021, Oct, 11;185(5):707\u201315. https:\/\/doi.org\/10.1530\/EJE-21-0634. PMID: 34519275","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"282_CR91","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/MED.0000000000000825","volume":"30","author":"LC Burrage","year":"2023","unstructured":"Burrage LC, McLeod DSA, Jordan SJ. Obesity and thyroid cancer risk. Curr Opin Endocrinol Diabetes Obes. 2023, Oct, 1;30(5):244\u201351. https:\/\/doi.org\/10.1097\/MED.0000000000000825. Epub 2023 Jul 6. PMID: 37410455","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"63","key":"282_CR92","doi-asserted-by":"publisher","first-page":"423","DOI":"10.15557\/JoU.2015.0039","volume":"15","author":"J Szczyrski","year":"2015","unstructured":"Szczyrski J, Kosiak W, Korpal-Szczyrska M, My\u015bliwiec M. Ultrasound image of the thyroid gland in obese children. J Ultrason. 2015, Dec;15(63):423\u201328. https:\/\/doi.org\/10.15557\/JoU.2015.0039. Epub 2015 Dec 28. PMID: 26807299; PMCID: PMC4710693.Adiposity is associated with a higher number of thyroid nodules and worse fine-needle aspiration outcomes.European Thyroid Journal","journal-title":"J Ultrason"},{"issue":"7","key":"282_CR93","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1210\/jc.2018-02399","volume":"104","author":"MR Licenziati","year":"2019","unstructured":"Licenziati MR, Valerio G, Vetrani I, Maria GD, Liotta F, Radetti G. Altered thyroid function and structure in children and adolescents who are overweight and obese: reversal after weight loss. The J Clin Endocrinol Metab. 2019, July;104(7):2757\u201365. https:\/\/doi.org\/10.1210\/jc.2018-02399","journal-title":"The J Clin Endocrinol Metab"},{"issue":"1","key":"282_CR94","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/nu16010087","volume":"16","author":"B Biondi","year":"2023","unstructured":"Biondi B. Subclinical hypothyroidism in patients with obesity and metabolic syndrome: a Narrative review. Nutrients. 2023, Dec, 27;16(1):87. https:\/\/doi.org\/10.3390\/nu16010087. PMID: 38201918; PMCID: PMC10780356","journal-title":"Nutrients"},{"issue":"26","key":"282_CR95","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1056\/NEJMcp1611144","volume":"376","author":"RP Peeters","year":"2017","unstructured":"Peeters RP. Subclinical hypothyroidism. N Engl J Med. 2017, Jun, 29;376(26):2556\u201365. https:\/\/doi.org\/10.1056\/NEJMcp1611144. PMID: 28657873","journal-title":"N Engl J Med"},{"issue":"11","key":"282_CR96","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1089\/thy.2019.0251","volume":"29","author":"V Papoian","year":"2019","unstructured":"Papoian V, Ylli D, Felger EA, Wartofsky L, Rosen JE. Evaluation of thyroid hormone replacement dosing in overweight and obese patients after a thyroidectomy. Thyroid. 2019, Nov;29(11):1558\u201362. https:\/\/doi.org\/10.1089\/thy.2019.0251. Epub 2019 Oct 1. PMID: 31573413","journal-title":"Thyroid"},{"issue":"25","key":"282_CR97","doi-asserted-by":"publisher","first-page":"100264","DOI":"10.1016\/j.jcte.2021.100264","volume":"30","author":"G Ratanapornsompong","year":"2021","unstructured":"Ratanapornsompong G, Sriphrapradang C. Appropriate dose of levothyroxine replacement therapy for hypothyroid obese patients. J Clin Transl Endocrinol. 2021, Jul;30(25):100264. https:\/\/doi.org\/10.1016\/j.jcte.2021.100264. PMID: 34401353; PMCID: PMC8350177","journal-title":"J Clin Transl Endocrinol"},{"key":"282_CR98","doi-asserted-by":"publisher","unstructured":"Liu W, You D, Lin J, Zou H, Zhang L, Luo S, Yuan Y, Wang Z, Qi J, Wang W, Ye X, Yang X, Deng Y, Teng F, Zheng X, Lin Y, Huang Z, Huang Y, Yang Z, Zhou X, Zhang Y, Chen R, Xu L, Li J, Yang W, Zhang H. SGLT2 inhibitor promotes ketogenesis to improve mash by suppressing CD8+ T cell activation. Cell Metab. 2024, Oct, 1;36(10):2245\u201361.e6. https:\/\/doi.org\/10.1016\/j.cmet.2024.08.005. Epub 2024 Sep 6.Erratum in:Cell Metab.2024 Nov5; 36(11):2489. https:\/\/doi.org\/10.1016\/j.cmet.2024.10.009. PMID: 39243758.","DOI":"10.1016\/j.cmet.2024.08.005"},{"issue":"10","key":"282_CR99","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1136\/ard-2023-224242","volume":"82","author":"XY Zhao","year":"2023","unstructured":"Zhao XY, Li SS, He YX, Yan LJ, Lv F, Liang QM, Gan YH, Han LP, Xu HD, Li YC, Qi YY. SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy. Ann Rheum Dis. 2023, Oct;82(10):1328\u201340. https:\/\/doi.org\/10.1136\/ard-2023-224242. Epub 2023 Jul 24. PMID: 37487609","journal-title":"Ann Rheum Dis"},{"key":"282_CR100","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.7150\/thno.54498","volume":"11","author":"Z Liu","year":"2021","unstructured":"Liu Z, Ma X, Ilyas I, Zheng X, Luo S, Little PJ, Kamato D, Sahebkar A, Wu W, Weng J, et al. Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics. Theranostics. 2021;11:4502\u201315","journal-title":"Theranostics"},{"key":"282_CR101","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s00125-019-4859-4","volume":"62","author":"HJL Heerspink","year":"2019","unstructured":"Heerspink HJL, Perco P, Mulder S, Leierer J, Hansen MK, Heinzel A, Mayer G. Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease. Diabetologia. 2019;62:1154\u201366","journal-title":"Diabetologia"},{"key":"282_CR102","doi-asserted-by":"publisher","first-page":"12417","DOI":"10.3390\/cimb46110737","volume":"46","author":"DH Kim","year":"2024","unstructured":"Kim DH, Lee MJ, Kang D, Lee JY, Park S, Khang AR, Bae JH, Kim JY, Kim SH, Kang YH, et al. Empagliflozin attenuates high-glucose-induced astrocyte activation and inflammation via NF-\u03baB pathway. Curr. Issues Mol. Biol. 2024;46:12417\u201327. https:\/\/doi.org\/10.3390\/cimb46110737","journal-title":"Curr. Issues Mol. Biol"},{"key":"282_CR103","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/ATVBAHA.119.312802","volume":"40","author":"TJ Barrett","year":"2020","unstructured":"Barrett TJ. Macrophages in atherosclerosis regression. Arterioscler. Thromb. Vasc. Biol. 2020;40:20\u201333","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"282_CR104","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4070\/kcj.2019.0296","volume":"50","author":"SG Lee","year":"2020","unstructured":"Lee SG, Lee SJ, Lee JJ, Kim JS, Lee OH, Kim CK, Kim D, Lee YH, Oh J, Park S, et al. Anti-inflammatory effect for atherosclerosis progression by sodium-glucose cotransporter 2 (SGLT-2) inhibitor in a normoglycemic rabbit model. Korean Circ. J. 2020;50:443\u201357","journal-title":"Korean Circ. J"},{"key":"282_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embr.201847202","volume":"20","author":"X Li","year":"2019","unstructured":"Li X, Hong X, Wang Y, Zhang S, Zhang J, Li X, Liu Y, Sun D, Feng Q, Ye J, et al. Tau accumulation triggers stat 1-dependent memory deficits by suppressing NMDA receptor expression. EMBO Rep. 2019;20:1\u201318","journal-title":"EMBO Rep"},{"key":"282_CR106","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3390\/ijms19072043","volume":"19","author":"Z Mao","year":"2018","unstructured":"Mao Z, Zhang W. Role of mTOR in glucose and lipid metabolism. Int. J. Mol. Sci. 2018;19:2043","journal-title":"Int. J. Mol. Sci"},{"key":"282_CR107","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12933-017-0529-3","volume":"16","author":"GP Fadini","year":"2017","unstructured":"Fadini GP, Bonora BM, Zatti G, Vitturi N, Iori E, Marescotti MC, Albiero M, Avogaro A. Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial. Cardiovasc. Diabetol. 2017;16:42","journal-title":"Cardiovasc. Diabetol"},{"key":"282_CR108","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/01.RES.0000194328.57164.36","volume":"97","author":"C Kobashi","year":"2005","unstructured":"Kobashi C, Urakaze M, Kishida M, Kibayashi E, Kobayashi H, Kihara S, Funahashi T, Takata M, Temaru R, Sato A, et al. Adiponectin inhibits endothelial synthesis of interleukin-8. Circ. Res. 2005;97:1245\u201352","journal-title":"Circ. Res"},{"key":"282_CR109","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1161\/01.CIR.0000018622.84402.FF","volume":"105","author":"Y Arita","year":"2002","unstructured":"Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002;105:2893\u201398","journal-title":"Circulation"},{"key":"282_CR110","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.metabol.2018.02.002","volume":"85","author":"WT Garvey","year":"2018","unstructured":"Garvey WT, Van Gaal L, Leiter LA, Vijapurkar U, List J, Cuddihy R, Ren J, Davies MJ. Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes. Metabolism. 2018;85:32\u201337","journal-title":"Metabolism"},{"key":"282_CR111","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.15420\/cfr.2022.11","volume":"8","author":"B Deschaine","year":"2022","unstructured":"Deschaine B, Verma S, Rayatzadeh H. Clinical evidence and Proposed mechanisms of sodium-glucose cotransporter 2 inhibitors in heart failure with Preserved Ejection Fraction: a class effect? Card. Fail. Rev. 2022;8:e23","journal-title":"Card. Fail. Rev"},{"key":"282_CR112","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12933-017-0658-8","volume":"17","author":"T Sato","year":"2018","unstructured":"Sato T, Aizawa Y, Yuasa S, Kishi S, Fuse K, Fujita S, Ikeda Y, Kitazawa H, Takahashi M, Sato M, et al. The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc. Diabetol. 2018;17:6","journal-title":"Cardiovasc. Diabetol"},{"key":"282_CR113","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1093\/eurheartj\/ehac481","volume":"43","author":"C Adamson","year":"2022","unstructured":"Adamson C, Kondo T, Jhund PS, De Boer RA, Cabrera Honorio JW, Claggett B, Desai AS, Alcocer Gamba MA, Al Habeeb W, Hernandez AF, et al. Dapagliflozin for heart failure according to body mass index: the deliver trial. Eur. Heart J. 2022;43:4406\u201317","journal-title":"Eur. Heart J"},{"key":"282_CR114","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385:1451\u201361","journal-title":"N. Engl. J. Med"},{"key":"282_CR115","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun. Rev. 2014;13:391\u201397","journal-title":"Autoimmun. Rev"},{"key":"282_CR116","doi-asserted-by":"publisher","first-page":"509764","DOI":"10.1155\/2013\/509764","volume":"2013","author":"MA Iddah","year":"2013","unstructured":"Iddah MA, Macharia BN. Autoimmune thyroid disorders. ISRN Endocrinol. 2013;2013:509764","journal-title":"ISRN Endocrinol"},{"key":"282_CR117","doi-asserted-by":"publisher","first-page":"5368473","DOI":"10.1155\/2019\/5368473","volume":"2019","author":"Y Hu","year":"2019","unstructured":"Hu Y, Zhang L, Chen H, Liu X, Zheng X, Shi H, Jiang L, Cui D. Analysis of regulatory T cell subsets and their expression of Helios and PD-1 in patients with Hashimoto Thyroiditis. Int. J. Endocrinol. 2019;2019:5368473","journal-title":"Int. J. Endocrinol"},{"key":"282_CR118","doi-asserted-by":"publisher","first-page":"102285","DOI":"10.1016\/j.jaut.2019.05.013","volume":"103","author":"D \u00c1lvarez-Sierra","year":"2019","unstructured":"\u00c1lvarez-Sierra D, Mar\u00edn-S\u00e1nchez A, Ruiz-Bl\u00e1zquez P, de Jes\u00fas Gil C, Iglesias-Felip C, Gonz\u00e1lez \u00d3, Casteras A, Costa RF, Nuciforo P, Colobran R, et al. Analysis of the PD-1\/PD-L1 axis in human autoimmune thyroid disease: insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity. J. Autoimmun. 2019;103:102285","journal-title":"J. Autoimmun"},{"key":"282_CR119","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cyto.2011.04.022","volume":"55","author":"A Antonelli","year":"2011","unstructured":"Antonelli A, Ferrari SM, Frascerra S, Galetta F, Franzoni F, Corrado A, Miccoli M, Benvenga S, Paolicchi A, Ferrannini E, et al. Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. Cytokine. 2011;55:288\u201393","journal-title":"Cytokine"},{"issue":"1","key":"282_CR120","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12935-022-02496-z","volume":"22","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yang L, Mao L, Zhang L, Zhu Y, Xu Y, Cheng Y, Sun R, Zhang Y, Ke J, Zhao D. SGLT2 inhibition restrains thyroid cancer growth via G1\/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways. Cancer Cell Int. 2022, Feb, 11;22(1):74. https:\/\/doi.org\/10.1186\/s12935-022-02496-z. PMID: 35148777; PMCID: PMC8840070","journal-title":"Cancer Cell Int"},{"issue":"5","key":"282_CR121","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/joim.13524","volume":"292","author":"L Bartalena","year":"2022","unstructured":"Bartalena L, Tanda ML. Current concepts regarding Graves\u2019 orbitopathy. J Intern Med. 2022, Nov;292(5):692\u2013716. https:\/\/doi.org\/10.1111\/joim.13524. Epub 2022 Jun 1. PMID: 35604323; PMCID: PMC9796560","journal-title":"J Intern Med"},{"key":"282_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10715762.2019.1702656","volume":"54","author":"GBN Chainy","year":"2020","unstructured":"Chainy GBN, Sahoo DK. Hormones and oxidative stress: an overview. Free Radic Res. 2020;54:1\u201326. https:\/\/doi.org\/10.1080\/10715762.2019.1702656","journal-title":"Free Radic Res"},{"issue":"3","key":"282_CR123","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.hfc.2019.02.008","volume":"15","author":"B Biondi","year":"2019","unstructured":"Biondi B. The Management of thyroid abnormalities in chronic heart failure. Heart Fail Clin. 2019, Jul;15(3):393\u201398. https:\/\/doi.org\/10.1016\/j.hfc.2019.02.008. Epub 2019 Apr 5. PMID: 31079697","journal-title":"Heart Fail Clin"},{"issue":"9","key":"282_CR124","doi-asserted-by":"publisher","first-page":"859608","DOI":"10.3389\/fcvm.2022.859608","volume":"12","author":"C Wang","year":"2022","unstructured":"Wang C, Han S, Li Y, Tong F, Li Z, Sun Z. Value of FT3\/FT4 ratio in prognosis of patients with heart failure: a propensity-matched study. Front Cardiovasc Med. 2022, Apr;12(9):859608. https:\/\/doi.org\/10.3389\/fcvm.2022.859608. PMID: 35498022; PMCID: PMC9039517","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"282_CR125","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.5001\/omj.2022.55","volume":"37","author":"I Al Fahdi","year":"2022","unstructured":"Al Fahdi I, Al Salmi I, Al Rahbi F, Shaheen F, Hannawi S. Thyroid dysfunction and kidney dysfunction. Oman Med J. 2022, May, 31;37(3):e377. https:\/\/doi.org\/10.5001\/omj.2022.55. PMID: 35814041; PMCID: PMC9207327","journal-title":"Oman Med J"},{"issue":"8","key":"282_CR126","doi-asserted-by":"publisher","first-page":"e2446","DOI":"10.1210\/clinem\/dgae841","volume":"110","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Hu H, Li W, Nie S, Zhou S, Chen Y, Cao T, Xu H, Liu B, Chen C, Liu H, Yang Q, Li H, Kong Y, Li G, Zha Y, Hu Y, Xu G, Shi Y, Zhou Y, Su G, Tang Y, Gong M, Wan Q. Chronic kidney disease and thyroid hormones. J Clin Endocrinol Metab. 2025, Jul, 15;110(8):e2446\u201355. https:\/\/doi.org\/10.1210\/clinem\/dgae841. PMID: 39657910","journal-title":"J Clin Endocrinol Metab"},{"key":"282_CR127","doi-asserted-by":"publisher","unstructured":"Makay B, Makay O, Yenisey C, Icoz G, Ozgen G, Unsal E, Akyildiz M, Yetkin E. The interaction of oxidative stress response with cytokines in the thyrotoxic rat: is there a link? Mediators Inflamm. 2009, 2009;391682. https:\/\/doi.org\/10.1155\/2009\/391682","DOI":"10.1155\/2009\/391682"},{"issue":"7","key":"282_CR128","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00424-024-02967-4","volume":"476","author":"N Bastawy","year":"2024","unstructured":"Bastawy N, El-Mosallamy AEMK, Aljuaydi SH, AbuBakr HO, Rasheed RA, Sadek AS, Khattab RT, Abualyamin WB, Abdelaal SE, Boushra AF. SGLT2 inhibitor as a potential therapeutic approach in hyperthyroidism-induced cardiopulmonary injury in rats. Pflugers Arch. 2024, Jul;476(7):1125\u201343. https:\/\/doi.org\/10.1007\/s00424-024-02967-4. Epub 2024 May 3. PMID: 38700719; PMCID: PMC1116678","journal-title":"Pflugers Arch"},{"issue":"2025","key":"282_CR129","doi-asserted-by":"publisher","first-page":"9920286","DOI":"10.1155\/ije\/9920286","volume":"17","author":"M Sanjari","year":"2025","unstructured":"Sanjari M, Sadeghi N, Amirkhosravi L, Hadavizadeh M, Naghibzadeh-Tahami A, Safi Z. Effect of empagliflozin on serum levels of thyroid hormones among prediabetic and diabetic patients. Int J Endocrinol. 2025, Apr;17(2025):9920286. https:\/\/doi.org\/10.1155\/ije\/9920286. PMID: 40276276; PMCID: PMC12021486","journal-title":"Int J Endocrinol"},{"issue":"9","key":"282_CR130","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1055\/s-2005-870419","volume":"37","author":"JM Steinacker","year":"2005","unstructured":"Steinacker JM, Brkic M, Simsch C, Nething K, Kresz A, Prokopchuk O, Liu Y. Thyroid hormones, cytokines, physical training and metabolic control. Horm Metab Res. 2005, Sep;37(9):538\u201344. https:\/\/doi.org\/10.1055\/s-2005-870419. PMID: 16175490","journal-title":"Horm Metab Res"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-025-00282-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-025-00282-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-025-00282-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T18:34:01Z","timestamp":1767638041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13044-025-00282-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1186\/s13044-025-00282-3","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}